EUVIMED · CrossrefZeitschrift
Expert Review of Anticancer Therapy
ISSN 1473-7140 · Informa UK Limited
Neueste Artikel
Evaluating vorasidenib in the treatment of IDH1-mutant or IDH2-mutant low-grade gliomas
Biological state–guided oncology: a framework for dynamic precision cancer care through oncological state transitions
Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategies
TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome
Survivorship in gynecological cancers: addressing psychosocial and physical challenges
The potential impact of glucagon-like peptide 1 receptor agonists for the treatment of endometrial carcinoma
Central nervous system-related permanent consequences in long-term survivors of pediatric Langerhans cell histiocytosis: a clinical overview and monitoring strategies
Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine
The dual role of Schlafen11 in brain tumors: Jekyll and Hyde
Association of neoadjuvant chemotherapy with outcomes in patients with elevated preoperative Ca 19–9 undergoing pancreatic ductal adenocarcinoma resection
Immune checkpoint inhibitors in people living with HIV and cancer: a Kaplan–Meier-derived individual patient data meta-analysis
The burden of acute myeloid leukemia: an integrated review of clinical, economic, and patient-centered evidence
An evaluation of retifanlimab-dlwr with carboplatin and paclitaxel and as a single agent for squamous cell carcinoma of the anal canal
The transcriptional landscape in thyroid cancer: current status of circulating biomarkers and liquid biopsy approaches
Overcoming therapeutic resistance in biliary tract cancer: from resistance mechanisms to dynamic precision oncology – a narrative review
Myelodysplastic syndromes/neoplasms presenting with isolated thrombocytopenia: a poorly understood pathophysiology, difficult to diagnose, and challenging to treat entity
Uveal melanoma: innovations in therapy, prognosis, and imaging
Targeting KIT and PDGFRA mutations in advanced GIST: current and future clinical implications
Antibody–drug conjugates: a practical review on clinical management of toxicities
Concomitant use of H1 antihistamines improves survival outcomes in cancer patients on immune checkpoint inhibitor therapy: a systematic review and meta-analysis
Elacestrant in metastatic breast cancer: current advancements and future perspectives
CRISPR–mRNA synergy: toward adaptive cancer immunotherapy
Targeting angiogenesis in cancer therapy: lessons learned and paths forward
Genomic divergence between matched primary and metastatic tumors across cancer types: a pan-cancer analysis of 5,692 samples
Prognostic and clinicopathological value of myeloid-derived suppressor cells in lung cancer: a comprehensive systematic review and meta-analysis
Nanotechnology meets liver cancer: liposomal immunotherapy strategies for hepatocellular carcinoma
Drugging the DNA damage response in the clinic: going beyond PARP
Association of RAD51 expression with response to neoadjuvant treatment and prognosis in locally advanced gastric cancer
Recent advances in the management of intrahepatic cholangiocarcinoma: the role of actionable mutations and targeted therapies
Established and emerging biomarkers approaches in urothelial carcinoma
EUVIMED